| renin angiotensin regulation of aldosterone production | GO:0002018 | 3 | 0.999 | |
| regulation of renal output by angiotensin | GO:0002019 | 2 | 0.999 | |
| positive regulation of blood pressure | GO:0045777 | 21 | 0.981 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.972 | Rat |
| cholesterol esterification | GO:0034435 | 3 | 0.970 | Human |
| renal system process involved in regulation of systemic arterial blood pressure | GO:0003071 | 15 | 0.966 | |
| activation of janus kinase activity | GO:0042976 | 2 | 0.966 | Human |
| drinking behavior | GO:0042756 | 5 | 0.963 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.944 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.934 | |
| sterol esterification | GO:0034434 | 3 | 0.924 | Human |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902238 | 1 | 0.921 | |
| regulation of cholesterol esterification | GO:0010872 | 2 | 0.914 | Human |
| regulation of systemic arterial blood pressure by renin angiotensin | GO:0003081 | 20 | 0.896 | |
| positive regulation of cholesterol esterification | GO:0010873 | 1 | 0.896 | Human |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.877 | |
| regulation of phospholipase a2 activity | GO:0032429 | 3 | 0.861 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.857 | |
| negative regulation of smooth muscle cell apoptotic process | GO:0034392 | 1 | 0.812 | |
| intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1990127 | 1 | 0.793 | |
| steroid esterification | GO:0034433 | 3 | 0.783 | Human |
| small molecule catabolic process | GO:0044282 | 71 | 0.742 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.734 | Mouse |
| superoxide anion generation | GO:0042554 | 11 | 0.730 | Rat |
| negative regulation of heart rate | GO:0010459 | 4 | 0.728 | |
| hormone metabolic process | GO:0042445 | 86 | 0.726 | |
| regulation of systemic arterial blood pressure by circulatory renin angiotensin | GO:0001991 | 13 | 0.718 | |
| oxidation reduction process | GO:0055114 | 342 | 0.698 | |
| circulatory system process | GO:0003013 | 197 | 0.695 | |
| kidney epithelium development | GO:0072073 | 121 | 0.688 | |
| negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902239 | 1 | 0.685 | |
| response to peptide hormone | GO:0043434 | 127 | 0.678 | Mouse |
| regulation of hormone levels | GO:0010817 | 211 | 0.677 | |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | GO:1902218 | 1 | 0.674 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.648 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.646 | Rat |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.638 | |
| phospholipase c activating angiotensin activated signaling pathway | GO:0086097 | 1 | 0.636 | |
| blood circulation | GO:0008015 | 195 | 0.632 | |
| intrinsic apoptotic signaling pathway in response to osmotic stress | GO:0008627 | 2 | 0.620 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.606 | Mouse |
| inflammatory response | GO:0006954 | 244 | 0.597 | |
| hexose metabolic process | GO:0019318 | 98 | 0.586 | Mouse |
| cellular amine metabolic process | GO:0044106 | 44 | 0.578 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.578 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.573 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.566 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.556 | |
| cation homeostasis | GO:0055080 | 212 | 0.555 | Rat |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.555 | Mouse |
| renal response to blood flow involved in circulatory renin angiotensin regulation of systemic arterial blood pressure | GO:0001999 | 6 | 0.547 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.535 | Rat |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.534 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.521 | |
| nephron development | GO:0072006 | 109 | 0.518 | |
| renal tubule development | GO:0061326 | 87 | 0.516 | |
| urogenital system development | GO:0001655 | 261 | 0.509 | |
| steroid metabolic process | GO:0008202 | 119 | 0.500 | Human Mouse |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.498 | |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.497 | Mouse |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.495 | |
| response to alcohol | GO:0097305 | 48 | 0.490 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.485 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.483 | Mouse |
| glucocorticoid metabolic process | GO:0008211 | 9 | 0.469 | Mouse |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.467 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.459 | |
| lipid catabolic process | GO:0016042 | 69 | 0.451 | |
| angiogenesis | GO:0001525 | 201 | 0.448 | Rat |
| triglyceride metabolic process | GO:0006641 | 51 | 0.447 | Mouse |
| renal system development | GO:0072001 | 225 | 0.445 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.430 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.426 | |
| rhythmic process | GO:0048511 | 174 | 0.398 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.389 | Mouse |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.386 | Mouse |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.381 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.376 | |
| nephron epithelium development | GO:0072009 | 92 | 0.376 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.368 | Human Mouse |
| alcohol biosynthetic process | GO:0046165 | 43 | 0.365 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.364 | Mouse |
| regulation of response to osmotic stress | GO:0047484 | 3 | 0.362 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.358 | Human |
| carboxylic acid transport | GO:0046942 | 100 | 0.357 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.356 | Mouse |
| regulation of superoxide anion generation | GO:0032928 | 4 | 0.353 | Rat |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.345 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.341 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.336 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.333 | Mouse |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.332 | |
| calcium ion transport | GO:0006816 | 159 | 0.326 | Rat |
| cytokine production | GO:0001816 | 319 | 0.321 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.320 | Mouse |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.315 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.313 | |
| vitamin d3 metabolic process | GO:0070640 | 3 | 0.313 | |
| response to nutrient levels | GO:0031667 | 109 | 0.312 | |
| endocrine process | GO:0050886 | 39 | 0.310 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.309 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.309 | |
| peptide hormone processing | GO:0016486 | 9 | 0.296 | |
| renal system process | GO:0003014 | 48 | 0.296 | |
| response to dexamethasone | GO:0071548 | 8 | 0.295 | |
| response to inorganic substance | GO:0010035 | 96 | 0.292 | |
| response to osmotic stress | GO:0006970 | 21 | 0.290 | |
| body fluid secretion | GO:0007589 | 53 | 0.289 | |
| regulation of secretion | GO:0051046 | 274 | 0.288 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.285 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.283 | Rat |
| response to organic cyclic compound | GO:0014070 | 198 | 0.279 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.279 | |
| angiotensin activated signaling pathway | GO:0038166 | 4 | 0.278 | |
| sterol metabolic process | GO:0016125 | 58 | 0.278 | Mouse |
| nucleoside metabolic process | GO:0009116 | 246 | 0.275 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.274 | Mouse |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.274 | |
| anion transport | GO:0006820 | 177 | 0.271 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.271 | Mouse |
| response to vitamin d | GO:0033280 | 3 | 0.270 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.267 | |
| cellular response to peptide | GO:1901653 | 92 | 0.263 | Mouse |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.261 | Mouse Rat |
| nitrogen compound transport | GO:0071705 | 271 | 0.260 | Rat |
| negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | GO:1902219 | 1 | 0.259 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.259 | Mouse |
| chemotaxis | GO:0006935 | 247 | 0.255 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.254 | |
| cation transport | GO:0006812 | 399 | 0.246 | Rat |
| regulation of blood vessel size | GO:0050880 | 56 | 0.245 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.243 | Mouse |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.242 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.241 | Rat |
| regulation of kinase activity | GO:0043549 | 249 | 0.237 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.236 | Mouse |
| alcohol catabolic process | GO:0046164 | 16 | 0.233 | |
| g protein coupled receptor signaling pathway coupled to cgmp nucleotide second messenger | GO:0007199 | 1 | 0.229 | |
| negative regulation of systemic arterial blood pressure | GO:0003085 | 15 | 0.227 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.226 | |
| vasodilation by angiotensin involved in regulation of systemic arterial blood pressure | GO:0002033 | 2 | 0.223 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.220 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.219 | |
| regulation of gluconeogenesis | GO:0006111 | 30 | 0.218 | Mouse |
| response to peptide | GO:1901652 | 136 | 0.215 | Mouse |
| gluconeogenesis | GO:0006094 | 39 | 0.215 | Mouse |
| phospholipid metabolic process | GO:0006644 | 87 | 0.214 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.213 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.209 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.207 | |
| negative regulation of peptidyl serine phosphorylation | GO:0033137 | 10 | 0.202 | |
| response to corticosteroid | GO:0031960 | 20 | 0.202 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.201 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.201 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.198 | |
| heart contraction | GO:0060047 | 93 | 0.198 | |
| amine metabolic process | GO:0009308 | 45 | 0.195 | |
| positive regulation of metanephric glomerulus development | GO:0072300 | 4 | 0.194 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.194 | |
| glomerulus development | GO:0032835 | 40 | 0.193 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.191 | Human |
| metal ion homeostasis | GO:0055065 | 189 | 0.190 | Rat |
| heart process | GO:0003015 | 94 | 0.190 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.187 | Rat |
| tissue remodeling | GO:0048771 | 102 | 0.184 | Rat |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.184 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.181 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.181 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.178 | |
| regulation of protein transport | GO:0051223 | 163 | 0.178 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.176 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.173 | |
| one carbon metabolic process | GO:0006730 | 1 | 0.173 | |
| renal system process involved in regulation of blood volume | GO:0001977 | 4 | 0.173 | |
| ovulation from ovarian follicle | GO:0001542 | 9 | 0.173 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.173 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.172 | |
| regulation of tube size | GO:0035150 | 57 | 0.171 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.171 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.170 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.170 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.169 | |
| kidney development | GO:0001822 | 213 | 0.168 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.167 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.165 | Human |
| receptor recycling | GO:0001881 | 11 | 0.164 | |
| amide transport | GO:0042886 | 138 | 0.164 | |
| glucocorticoid biosynthetic process | GO:0006704 | 5 | 0.163 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.162 | Rat |
| cofactor metabolic process | GO:0051186 | 80 | 0.161 | |
| water transport | GO:0006833 | 12 | 0.160 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.160 | Rat |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.157 | Rat |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.153 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.152 | |
| glucose metabolic process | GO:0006006 | 92 | 0.152 | Mouse |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.151 | |
| fatty acid derivative metabolic process | GO:1901568 | 33 | 0.151 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.150 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.148 | |
| leukocyte migration | GO:0050900 | 124 | 0.148 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.147 | |
| response to corticosterone | GO:0051412 | 1 | 0.147 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.144 | |
| metanephric glomerular mesangium development | GO:0072223 | 3 | 0.144 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.141 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.141 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.141 | |
| positive regulation of systemic arterial blood pressure | GO:0003084 | 9 | 0.138 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.137 | |
| response to insulin | GO:0032868 | 100 | 0.136 | Mouse |
| steroid catabolic process | GO:0006706 | 7 | 0.136 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.136 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.135 | |
| negative regulation of blood pressure | GO:0045776 | 22 | 0.135 | |
| peptide metabolic process | GO:0006518 | 46 | 0.134 | |
| positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway | GO:0010579 | 3 | 0.134 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.133 | |
| regulation of system process | GO:0044057 | 200 | 0.132 | Rat |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.132 | Mouse |
| calcium ion homeostasis | GO:0055074 | 127 | 0.131 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.130 | Mouse |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.128 | |
| lipid modification | GO:0030258 | 65 | 0.128 | Human |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.128 | Mouse |
| cholesterol metabolic process | GO:0008203 | 56 | 0.128 | Mouse |
| response to steroid hormone | GO:0048545 | 56 | 0.126 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.126 | |
| drug metabolic process | GO:0017144 | 4 | 0.125 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.124 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.124 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.123 | |
| metanephric glomerulus development | GO:0072224 | 13 | 0.123 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.122 | |
| response to acid chemical | GO:0001101 | 111 | 0.121 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.120 | Mouse |
| cellular homeostasis | GO:0019725 | 240 | 0.119 | Rat |
| innate immune response | GO:0045087 | 157 | 0.118 | |
| renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure | GO:0003072 | 5 | 0.117 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.117 | Human |
| nephron morphogenesis | GO:0072028 | 69 | 0.116 | |
| camera type eye development | GO:0043010 | 266 | 0.116 | |
| fat soluble vitamin metabolic process | GO:0006775 | 11 | 0.114 | |
| regulation of adrenergic receptor signaling pathway | GO:0071877 | 4 | 0.114 | |
| response to glucocorticoid | GO:0051384 | 20 | 0.113 | |
| response to drug | GO:0042493 | 75 | 0.112 | |
| sensory perception | GO:0007600 | 245 | 0.111 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.110 | Mouse |
| response to monosaccharide | GO:0034284 | 67 | 0.110 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.110 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.109 | |
| calcitriol biosynthetic process from calciol | GO:0036378 | 3 | 0.107 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.106 | |
| coenzyme metabolic process | GO:0006732 | 52 | 0.106 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.105 | Rat |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.104 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.103 | |
| drug catabolic process | GO:0042737 | 2 | 0.103 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.103 | Mouse |
| regulation of blood vessel size by renin angiotensin | GO:0002034 | 5 | 0.103 | |
| organic acid transport | GO:0015849 | 101 | 0.103 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.102 | |
| gland development | GO:0048732 | 330 | 0.102 | |
| glutamate metabolic process | GO:0006536 | 9 | 0.101 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.100 | Mouse |
| muscle cell differentiation | GO:0042692 | 261 | 0.100 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.098 | Mouse |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.098 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.098 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.098 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.098 | |
| regulation of lipase activity | GO:0060191 | 15 | 0.097 | Rat |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.097 | Mouse |
| regulation of superoxide metabolic process | GO:0090322 | 8 | 0.097 | Rat |
| plasma lipoprotein particle remodeling | GO:0034369 | 6 | 0.097 | |
| response to metal ion | GO:0010038 | 47 | 0.096 | |
| mesonephros development | GO:0001823 | 97 | 0.096 | |
| nephron tubule development | GO:0072080 | 84 | 0.096 | |
| adrenal gland development | GO:0030325 | 18 | 0.095 | |
| c21 steroid hormone biosynthetic process | GO:0006700 | 3 | 0.094 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.094 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.093 | Mouse |
| dibenzo p dioxin metabolic process | GO:0018894 | 1 | 0.093 | |
| regulation of glutamate metabolic process | GO:2000211 | 1 | 0.093 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.093 | |
| cell chemotaxis | GO:0060326 | 81 | 0.093 | |
| response to oxidative stress | GO:0006979 | 123 | 0.092 | |
| response to glucagon | GO:0033762 | 3 | 0.092 | |
| protein maturation | GO:0051604 | 176 | 0.092 | Mouse |
| metanephric nephron development | GO:0072210 | 34 | 0.091 | |
| vasoconstriction | GO:0042310 | 27 | 0.091 | |
| cellular response to lipid | GO:0071396 | 145 | 0.091 | |
| protein secretion | GO:0009306 | 111 | 0.090 | |
| tissue migration | GO:0090130 | 68 | 0.090 | Human |
| regulation of metanephric glomerulus development | GO:0072298 | 5 | 0.089 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.089 | |
| lipid transport | GO:0006869 | 98 | 0.088 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.088 | |
| potassium ion homeostasis | GO:0055075 | 4 | 0.087 | |
| intrinsic apoptotic signaling pathway by p53 class mediator | GO:0072332 | 35 | 0.086 | |
| positive regulation of fatty acid biosynthetic process | GO:0045723 | 3 | 0.086 | |
| ovulation | GO:0030728 | 15 | 0.085 | |
| regulation of receptor recycling | GO:0001919 | 8 | 0.084 | |
| cell adhesion | GO:0007155 | 329 | 0.084 | |
| protein glycosylation | GO:0006486 | 55 | 0.083 | Mouse |
| positive regulation of monooxygenase activity | GO:0032770 | 2 | 0.083 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.083 | |
| protein processing | GO:0016485 | 163 | 0.083 | Mouse |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.082 | |
| regulation of morphogenesis of a branching structure | GO:0060688 | 53 | 0.082 | Human |
| regulation of metal ion transport | GO:0010959 | 106 | 0.082 | Rat |
| glycosylation | GO:0070085 | 62 | 0.082 | Mouse |
| unsaturated fatty acid metabolic process | GO:0033559 | 31 | 0.081 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.080 | |
| sodium ion transport | GO:0006814 | 73 | 0.080 | |
| epithelial cell migration | GO:0010631 | 63 | 0.080 | Human |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.080 | |
| response to water deprivation | GO:0009414 | 1 | 0.079 | |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.078 | |
| polysaccharide metabolic process | GO:0005976 | 39 | 0.078 | |
| regulation of nitrogen cycle metabolic process | GO:1903314 | 1 | 0.078 | |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.078 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.077 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.076 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.076 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.075 | |
| renin secretion into blood stream | GO:0002001 | 5 | 0.075 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.075 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.074 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.074 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.074 | |
| regulation of ion transport | GO:0043269 | 215 | 0.073 | Rat |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.073 | |
| amino acid transport | GO:0006865 | 61 | 0.072 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.071 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.071 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.070 | |
| cartilage development | GO:0051216 | 140 | 0.070 | |
| beta amyloid metabolic process | GO:0050435 | 14 | 0.069 | |
| inorganic anion transport | GO:0015698 | 43 | 0.068 | |
| sterol homeostasis | GO:0055092 | 45 | 0.067 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.067 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.067 | Mouse |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.067 | |
| response to ketone | GO:1901654 | 15 | 0.067 | |
| organic anion transport | GO:0015711 | 137 | 0.066 | |
| cellular glucan metabolic process | GO:0006073 | 32 | 0.066 | |
| axonogenesis | GO:0007409 | 274 | 0.066 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.065 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.065 | |
| glucose homeostasis | GO:0042593 | 128 | 0.065 | |
| metanephric nephron epithelium development | GO:0072243 | 19 | 0.065 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.064 | |
| digestion | GO:0007586 | 40 | 0.064 | |
| lipid localization | GO:0010876 | 126 | 0.064 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.064 | Rat |
| exogenous drug catabolic process | GO:0042738 | 1 | 0.063 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.063 | Rat |
| regulation of intrinsic apoptotic signaling pathway by p53 class mediator | GO:1902253 | 13 | 0.062 | |
| positive regulation of steroid metabolic process | GO:0045940 | 5 | 0.062 | Human |
| cellular response to dexamethasone stimulus | GO:0071549 | 8 | 0.062 | |
| vasodilation | GO:0042311 | 28 | 0.062 | Rat |
| protein lipid complex subunit organization | GO:0071825 | 12 | 0.061 | |
| folic acid containing compound metabolic process | GO:0006760 | 3 | 0.061 | |
| sensory perception of pain | GO:0019233 | 47 | 0.061 | |
| negative regulation of phagocytosis | GO:0050765 | 4 | 0.060 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 33 | 0.060 | |
| maternal process involved in female pregnancy | GO:0060135 | 32 | 0.060 | |
| ammonia assimilation cycle | GO:0019676 | 2 | 0.059 | |
| response to estrogen | GO:0043627 | 24 | 0.059 | |
| dicarboxylic acid transport | GO:0006835 | 29 | 0.059 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.059 | Mouse |
| renal sodium ion transport | GO:0003096 | 2 | 0.059 | |
| response to starvation | GO:0042594 | 65 | 0.059 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.059 | |
| regulation of protein processing | GO:0070613 | 96 | 0.059 | Mouse |
| neuron apoptotic process | GO:0051402 | 142 | 0.058 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.058 | |
| cellular alcohol biosynthetic process | GO:0044108 | 3 | 0.058 | |
| triglyceride rich lipoprotein particle remodeling | GO:0034370 | 2 | 0.058 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.058 | |
| positive regulation of growth hormone secretion | GO:0060124 | 3 | 0.058 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.057 | |
| multicellular organism growth | GO:0035264 | 161 | 0.057 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.057 | Mouse |
| positive regulation of peptide secretion | GO:0002793 | 33 | 0.057 | |
| very low density lipoprotein particle remodeling | GO:0034372 | 1 | 0.057 | |
| urea transmembrane transport | GO:0071918 | 2 | 0.057 | |
| response to water | GO:0009415 | 1 | 0.057 | |
| regulation of glycogen metabolic process | GO:0070873 | 13 | 0.056 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.056 | Human |
| cellular response to cadmium ion | GO:0071276 | 3 | 0.056 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.056 | Human Mouse |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.056 | Mouse |
| fat cell differentiation | GO:0045444 | 160 | 0.056 | |
| skeletal system development | GO:0001501 | 356 | 0.055 | |
| endothelial cell migration | GO:0043542 | 44 | 0.055 | Human |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.055 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.054 | |
| regulation of serotonin uptake | GO:0051611 | 2 | 0.054 | |
| organic hydroxy compound catabolic process | GO:1901616 | 25 | 0.054 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.054 | |
| cellular polysaccharide metabolic process | GO:0044264 | 38 | 0.054 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.054 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.054 | |
| regulation of angiotensin levels in blood | GO:0002002 | 4 | 0.053 | |
| regulation of carbohydrate biosynthetic process | GO:0043255 | 40 | 0.053 | Mouse |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.053 | |
| secondary metabolic process | GO:0019748 | 18 | 0.052 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.052 | |
| metanephric tubule development | GO:0072170 | 18 | 0.052 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.052 | |
| lactation | GO:0007595 | 25 | 0.052 | |
| regulation of protein localization | GO:0032880 | 231 | 0.052 | |
| lipid homeostasis | GO:0055088 | 63 | 0.051 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.051 | |
| cellular response to water deprivation | GO:0042631 | 1 | 0.051 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.051 | Rat |
| macromolecule glycosylation | GO:0043413 | 55 | 0.051 | Mouse |
| cholesterol catabolic process | GO:0006707 | 5 | 0.051 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.051 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.050 | |
| l amino acid transport | GO:0015807 | 32 | 0.050 | |
| sulfur compound biosynthetic process | GO:0044272 | 37 | 0.050 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.050 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.050 | |
| regulation of cell motility | GO:2000145 | 236 | 0.049 | Human |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.049 | |
| progesterone metabolic process | GO:0042448 | 4 | 0.049 | |
| response to bile acid | GO:1903412 | 1 | 0.049 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.048 | |
| fluid transport | GO:0042044 | 14 | 0.048 | |
| axon ensheathment | GO:0008366 | 76 | 0.048 | |
| lymphocyte migration | GO:0072676 | 26 | 0.048 | |
| response to oxygen levels | GO:0070482 | 62 | 0.048 | |
| action potential | GO:0001508 | 78 | 0.048 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.048 | |
| peptide secretion | GO:0002790 | 114 | 0.047 | |
| glycogen metabolic process | GO:0005977 | 32 | 0.047 | |
| regulation of circadian sleep wake cycle | GO:0042749 | 3 | 0.047 | |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.047 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.046 | Rat |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.046 | |
| ureteric bud development | GO:0001657 | 94 | 0.046 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.046 | |
| plasma lipoprotein particle assembly | GO:0034377 | 6 | 0.046 | |
| icosanoid metabolic process | GO:0006690 | 33 | 0.045 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.045 | Human Rat |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.045 | |
| regulation of circadian sleep wake cycle sleep | GO:0045187 | 3 | 0.045 | |
| response to radiation | GO:0009314 | 165 | 0.045 | |
| triglyceride homeostasis | GO:0070328 | 15 | 0.045 | |
| cognition | GO:0050890 | 149 | 0.045 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.045 | |
| water homeostasis | GO:0030104 | 27 | 0.045 | |
| adult behavior | GO:0030534 | 135 | 0.045 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.045 | |
| neuronal action potential | GO:0019228 | 54 | 0.045 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.045 | |
| catecholamine metabolic process | GO:0006584 | 30 | 0.044 | |
| vitamin biosynthetic process | GO:0009110 | 7 | 0.044 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.044 | Mouse |
| positive regulation of branching involved in ureteric bud morphogenesis | GO:0090190 | 18 | 0.044 | Human |
| cellular response to alcohol | GO:0097306 | 23 | 0.044 | |
| general adaptation syndrome | GO:0051866 | 2 | 0.044 | |
| biomineral tissue development | GO:0031214 | 64 | 0.043 | |
| cellularization | GO:0007349 | 1 | 0.043 | |
| negative regulation of camp mediated signaling | GO:0043951 | 3 | 0.043 | |
| intracellular protein transport | GO:0006886 | 204 | 0.043 | Rat |
| dephosphorylation | GO:0016311 | 129 | 0.043 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.043 | Mouse |
| regulation of angiogenesis | GO:0045765 | 81 | 0.043 | Rat |
| positive regulation of nitric oxide synthase activity | GO:0051000 | 2 | 0.043 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.043 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.043 | |
| regulation of lipoprotein lipase activity | GO:0051004 | 4 | 0.043 | |
| mineralocorticoid biosynthetic process | GO:0006705 | 1 | 0.042 | |
| response to amino acid | GO:0043200 | 37 | 0.042 | |
| regulation of neuron death | GO:1901214 | 134 | 0.042 | |
| negative regulation of intrinsic apoptotic signaling pathway | GO:2001243 | 34 | 0.042 | |
| phospholipase c activating g protein coupled receptor signaling pathway | GO:0007200 | 26 | 0.042 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.042 | Rat |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.042 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.042 | |
| protein lipid complex remodeling | GO:0034368 | 6 | 0.042 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.041 | Rat |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.041 | |
| sodium ion homeostasis | GO:0055078 | 7 | 0.041 | Rat |
| regulation of metanephros development | GO:0072215 | 15 | 0.041 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.041 | |
